相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The roles of TGF-β signaling in carcinogenesis and breast cancer metastasis
Takeshi Imamura et al.
BREAST CANCER (2012)
Breast cancer expression of YKL-40 correlates with tumour grade, poor differentiation, and other cancer markers
R. Shao et al.
BRITISH JOURNAL OF CANCER (2011)
YKL-40 expression in human hepatocellular carcinoma: a potential biomarker?
Xin-Qiang Xiao et al.
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL (2011)
Aldehyde dehydrogenase 1 expression is a predictor of poor prognosis in node-positive breast cancers: a long-term follow-up study
Takako Yoshioka et al.
HISTOPATHOLOGY (2011)
A YKL-40-Neutralizing Antibody Blocks Tumor Angiogenesis and Progression: A Potential Therapeutic Agent in Cancers
Michael Faibish et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Identification of proteins secreted by human osteoblastic cells in culture
Julia S. Johansen et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Prognostic significance of histological grading, p53 status, YKL-40 expression, and IDH1 mutations in pediatric high-grade gliomas
Manila Antonelli et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
Expression of the glioma-associated oncogene homolog (GLI) 1 in human breast cancer is associated with unfavourable overall survival
Anette ten Haaf et al.
BMC CANCER (2009)
YKL-40, a Marker of Inflammation and Endothelial Dysfunction, Is Elevated in Patients With Type 1 Diabetes and Increases With Levels of Albuminuria
Camilla Noelle Rathcke et al.
DIABETES CARE (2009)
Serum YKL-40 levels as a prognostic factor in patients with locally advanced breast cancer
Deniz Yamac et al.
ADVANCES IN THERAPY (2008)
YKL-40 is elevated in patients with chronic obstructive pulmonary disease and activates alveolar macrophages
Severine Letuve et al.
JOURNAL OF IMMUNOLOGY (2008)
Sonic hedgehog signaling promotes motility and invasiveness of gastric cancer cells through TGF-β-mediated activation of the ALK5-Smad 3 pathway
Young A. Yoo et al.
CARCINOGENESIS (2008)
YKL-40 protein expression is not a prognostic marker in patients with primary breast cancer
Anne Roslind et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
YKL-40 expression in benign and malignant lesions of the breast: A methodologic study
Anne Roslind et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2007)
A chitinase-like protein in the lung and circulation of patients with severe asthma
Geoffrey L. Chupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Induction of sonic hedgehog mediators by transforming growth factor-β:: Smad3-dependent activation of Gli2 and Gli1 expression in vitro and in vivo
Sylviane Dennler et al.
CANCER RESEARCH (2007)
Elevated serum level of YKL-40 is an independent prognostic factor for poor survival in patients with metastatic melanoma
H Schmidt et al.
CANCER (2006)
Determination of TGFβ1 protein level in human primary breast cancers and its relationship with survival
S Desruisseau et al.
BRITISH JOURNAL OF CANCER (2006)
Regulation of YKL-40 expression during genotoxic or microenvironmental stress in human glioblastoma cells
N Junker et al.
CANCER SCIENCE (2005)
High serum YKL-40 level in patients with small cell lung cancer is related to early death
JS Johansen et al.
LUNG CANCER (2004)
Crystal structure and carbohydrate-binding properties of the human cartilage glycoprotein-39
F Fusetti et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
gp38k (CHI3L1) is a novel adhesion and migration factor for vascular cells
KC Nishikawa et al.
EXPERIMENTAL CELL RESEARCH (2003)
High serum YKL-40 levels in patients with primary breast cancer is related to short recurrence free survival
JS Johansen et al.
BREAST CANCER RESEARCH AND TREATMENT (2003)
Plasma YKL-40, as a prognostic tumor marker in recurrent ovarian cancer
H Dehn et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2003)
High serum YKL-40 level after surgery for colorectal carcinoma is related to short survival
C Cintin et al.
CANCER (2002)
The chitinase 3-like protein human cartilage glycoprotein 39 (HC-gp39) stimulates proliferation of human connective-tissue cells and activates both extracellular signal-regulated kinase- and protein kinase β-mediated signalling pathways
AD Recklies et al.
BIOCHEMICAL JOURNAL (2002)
Studies on YKL-40 in knee joints of patients with rheumatoid arthritis and osteoarthritis. Involvement of YKL-40 in the joint pathology
B Volck et al.
OSTEOARTHRITIS AND CARTILAGE (2001)
分享论文
